Product Information

CYCLOSPORINE MODIFIED 25 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3429 per EA under NDC 00093901865. Its NADAC has been published 278 times since Jul 28, 2021.

FDA first approved this application on Mar 29, 2005. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CYCLOSPORINE MODIFIED 25 MG

Cyclosporine
$0.3429per EA

Strength

25 mg/1

NDC

00093901865

Classification

Generic

Dosage Form

CAPSULE, LIQUID FILLED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CYCLOSPORINE

Approval Type

Generic (ANDA)

FDA Application

ANDA065110

FDA Approved

3/29/2005

TE Code

AB1

On Market Since

6/8/2021

Pharmacological Classes

Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for CYCLOSPORINE MODIFIED 25 MG has been published 278 times since Jul 28, 2021, and over the history we have for it it has declined 44.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3429 per EA
All-time high$0.6559 (Sep 15, 2021)
All-time low$0.3100 (Apr 22, 2026)
52-week high$0.3429
52-week low$0.3100
Median price$0.4516
Average price$0.4422
Largest weekly change+53.8% (Aug 21, 2024)
Weeks tracked278
Tracking sinceJul 28, 2021

Price History

1W

+3.6%

1M

+9.3%

3M

+8.0%

6M

+9.2%

1Y

+3.6%

3Y

-23.6%

5Y

-33.8%

All

-44.4%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CYCLOSPORINE MODIFIED 25 MG?

The current National Average Drug Acquisition Cost (NADAC) for CYCLOSPORINE MODIFIED 25 MG, manufactured by Teva Pharmaceuticals USA Inc., is $0.3429 per EA (NDC 00093901865), effective Nov 18, 2026.

How has the price of CYCLOSPORINE MODIFIED 25 MG changed over time?

Over the history we have for it, the NADAC for CYCLOSPORINE MODIFIED 25 MG has declined 44.4%. It has been tracked across 278 weekly CMS publications since Jul 28, 2021.

What are the highest and lowest recorded NADAC prices for CYCLOSPORINE MODIFIED 25 MG?

Since Jul 28, 2021, the NADAC for CYCLOSPORINE MODIFIED 25 MG has ranged from a low of $0.3100 (Apr 22, 2026) to a high of $0.6559 (Sep 15, 2021), with a median of $0.4516 per EA.

Are there cheaper alternatives to CYCLOSPORINE MODIFIED 25 MG?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOSPORINE MODIFIED 25 MG, is $0.3184 per EA — about 7% below CYCLOSPORINE MODIFIED 25 MG.

Who manufactures CYCLOSPORINE MODIFIED 25 MG?

CYCLOSPORINE MODIFIED 25 MG (NDC 00093901865) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.